Published: March 10, 2011
Medtronic Introduces VERTEX SELECT CHROMALOY Plus Rods
MEMPHIS, Tenn. - (BUSINESS WIRE) - Continuing its leadership in cervical spine medical device therapies,
Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX
SELECT CHROMALOY Plus Rods. The announcement was
made at the 27th annual meeting of the American Association
of Neurological Surgeons/ Congress of Neurological Surgeons Section of
Disorders of the Spine and Peripheral Nerves in Phoenix.
The VERTEX SELECT CHROMALOY Plus Rod is a
supplement to the VERTEX SELECT Reconstruction System.
During a procedure, a surgeon uses the rods to connect existing or new
fusion systems in the patient's occipitocervical and upper-thoracic
spine. CHROMALOY Rods consist of cobalt chrome alloy
material with engineered features, including a blend of three metals
which, according to mechanical testing, help improve the rod's
biomechanical characteristics and maintain a more rigid overall
construct. The VERTEX SELECT Reconstruction System is
intended to provide stabilization to promote fusion.
"The addition of the CHROMALOY Plus Rods further
differentiates the VERTEX System by providing a surgeon a
choice among multiple rod diameters and material options to better
accommodate patient anatomy and pathology," said Doug King, Senior Vice
President and President of Medtronic Spinal.
The VERTEX SELECT Reconstruction System consists of implants
and general instruments that can be used to surgically treat patients
with a variety of conditions that can contribute to spinal instability,
including degenerative disc disease, spinal stenosis, fracture, tumors,
and/or spondylolisthesis. The VERTEX System product line has
more than 10 years of clinical experience and has been used in more than
100,000 cases.
Potential risks associated with the use of the device include, but are
not limited to: bending, and/or breakage of any or all of the
components. A successful result may not be achieved in every case.
About the Spine Business at Medtronic
The Spine business,
based in Memphis, Tenn., is the global leader in today's spine market
and is committed to advancing the treatment of spinal conditions. The
Spine business collaborates with world-renowned surgeons, researchers
and innovative partners to offer state-of-the-art products and
technologies for neurological, orthopaedic and spinal conditions.
Medtronic is committed to developing affordable, minimally invasive
procedures that provide lifestyle friendly surgical therapies. More
information about the company and its spinal treatments can be found at www.medtronicspinal.com
and its patient-education Web sites, www.back.com,
www.iscoliosis.com,
www.maturespine.com
and www.necksurgery.com.
About Medtronic
Medtronic, Inc. (www.medtronic.com),
headquartered in Minneapolis, is the global leader in medical technology
- alleviating pain, restoring health, and extending life for millions of
people around the world.
Any forward-looking statements are subject to risks and uncertainties
such as those described in Medtronic's periodic reports on file with the
Securities and Exchange Commission. Actual results may differ materially
from anticipated results.

Medtronic, Inc.
Public Relations:
Victor Rocha,
901-399-2401
or
Investor Relations:
Jeff Warren,
763-505-2696
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News